EC 2.7.11.21
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 4192 | (S)-BI 2536 | Dual PLK1/BRD4 bromodomain inhibitor | €170.00 | |
| 1129 | BI 2536 | PLK1 inhibitor | €60.00 | |
| 1473 | BI 6727 | PLK1 Inhibitor | €90.00 | |
| 3918 | CZS-241 hydrochloride | Highly potent, selective, and orally available PLK4 inhibitor | Recently added | €160.00 |
| 1688 | GSK 461364 | PLK1 inhibitor | €105.00 | |
| 1626 | GSK 461364 analogue II | PLK1 Inhibitor | €130.00 | |
| 1625 | GSK579289A | PLK1 Inhibitor | €110.00 | |
| 1131 | GW 843682X | PLK1 and PLK3 inhibitor | €85.00 | |
| 1910 | MLN0905 | PLK1 inhibitor | €95.00 | |
| 4007 | NMS-1286937 | Orally bioavailable PLK1 inhibitor | Inquire | |
| 2950 | Rigosertib sodium | Non-ATP-competitive PLK1 inhibitor | €95.00 | |